• Markets
    • icon
  • Companies
EVE · ASX

EVE Health Group Limited (ASX:EVE)

AU$0.001

 0.0 (0.0%)
ASX:Live
25/07/2024 12:00:00 AM
Near Support Near Resistance Near 52 Week Low Near 52 Week High HALO Ords +2
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

EVE Overview

EVE Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About EVE

Website

N/A

Telephone

61.8.6465.5500

Address

Suite 1 245 Churchill Avenue Subiaco, Western Australia (WA) 6008

Description

EVE Health Group Ltd. engages in the development and provision of health and wellness solutions. Its portfolio includes Omni Innovation, Meluka Australia, Jenbrook Australia, and Naturally Australian Products. It operates through the following segments: Jenbrook, Meluka, and Investment. The company was founded on October 1, 2003 and is headquartered in Subiaco, Australia.

EVE Price Chart

Key Stats

Market Cap

AU$5.27M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

AU$62.00

1 week

0%

1 month

0%

YTD

0%

1 year

0%

All time high

0.21

Key Fundamentals

EPS 3 yr Growth

33.300%

EBITDA Margin

-90.80%

Operating Cashflow

-$2m

Free Cash Flow Return

-31.50%

ROIC

-44.90%

Interest Coverage

N/A

Quick Ratio

3.60

Other Data

Shares on Issue (Fully Dilluted)

5274m

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

EVE Announcements

Latest Announcements

Date Announcements

30 April 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

30 April 24

Details of Auditor Appointment/Resignation

×

Details of Auditor Appointment/Resignation

02 April 24

Notification of cessation of securities - EVE

×

Notification of cessation of securities - EVE

28 February 24

Appendix 4D and Half Year Report

×

Appendix 4D and Half Year Report

31 January 24

Farm Sale and Funding Update

×

Farm Sale and Funding Update

31 January 24

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

24 November 23

New Constitution

×

New Constitution

23 November 23

Results of Annual General Meeting

×

Results of Annual General Meeting

21 November 23

Notification of cessation of securities - EVE

×

Notification of cessation of securities - EVE

21 November 23

Change of Director's Interest Notice

×

Change of Director's Interest Notice

26 October 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

25 October 23

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

25 October 23

Letter to Shareholders - AGM Notice

×

Letter to Shareholders - AGM Notice

09 October 23

Change of Director's Interest Notice

×

Change of Director's Interest Notice

29 September 23

Annual Report to shareholders

×

Annual Report to shareholders

29 September 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

27 September 23

Date of AGM and Closing Date for Director Nominations

×

Date of AGM and Closing Date for Director Nominations

30 August 23

Appendix 4E - Results for Announcement to the Market

×

Appendix 4E - Results for Announcement to the Market

31 July 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

27 April 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

28 February 23

Director Resignation

×

Director Resignation

27 February 23

Appendix 4D and Half Year Report

×

Appendix 4D and Half Year Report

31 January 23

Appendix 4C - December Quarter 2022

×

Appendix 4C - December Quarter 2022

20 December 22

Sale of Investment in Omni Innovation

×

Sale of Investment in Omni Innovation

24 November 22

Results of Meeting

×

Results of Meeting

EVE Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -33.3 -62.5 38.5 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 -0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -32.3 -20.4 38.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock -16.4 -94.7 -31.6 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock -25.5 -32.5 -56.2 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 4,587 4,011 5,219 Lock Lock Lock
Basic m Lock Lock Lock Lock 4,587 4,011 5,219 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 3 2 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 21.2 -14.7 -2.5 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 3 3 2 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -1 -1 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -57.9 -65.5 71.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -25.5 -49.4 -14.5 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 125 149 114 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -4 -4 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -42.4 -11.3 45.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -125.3 -163.4 -90.8 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -4 -4 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock -39.8 -10.4 46.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -136.9 -177.0 -97.9 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -3 -5 -2 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -4 -5 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -51.3 -48.0 24.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -129.6 -224.7 -173.5 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -2 -4 -2 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 1 2 0 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -3 -4 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 27.9 -51.5 56.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -0.9 -1.6 -0.7 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 3 1 0 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 12 8 4 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -2 -1 0 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 1 1 Lock Lock Lock
Equity $m Lock Lock Lock Lock 10 7 3 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 11 7 3 Lock Lock Lock
     Growth % Lock Lock Lock Lock -18.9 -33.2 -57.4 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -30.4 -66.5 -97.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -35.6 -77.5 -129.4 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -30.9 -45.4 -43.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -29.6 -58.7 -44.9 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -18.3 -41.2 -31.5 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -72.6 -276.9 N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.6 0.2 0.1 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -21.1 -8.8 -6.0 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 4.9 3.7 4.1 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 3.7 1.8 3.6 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 67.2 40.6 4.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -235.8 -507.6 -163.4 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 4.4 7.9 12.7 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 3.6 2.8 2.8 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.7 1.2 0.7 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 15.4 14.2 10.9 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.3 0.6 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.3 0.6 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -112.9 -210.4 -90.2 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -26.5 -62.3 -50.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -30.4 -66.5 -97.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.2 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -35.6 -77.5 -129.4 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -35.6 -77.5 -129.4 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 101.4 130.4 129.1 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 83.1 46.0 28.7 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 184.6 176.4 157.8 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 38.8 37.5 59.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 145.8 138.9 98.6 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

EVE Shortsell

Frequently Asked Questions

The current share price of EVE Health Group Limited (EVE:ASX) is AU$0.001.
The 52-week high share price for EVE Health Group Limited (EVE:ASX) is AU$0.00.
The 52-week low share price for EVE Health Group Limited (EVE:ASX)? is AU$0.00.
EVE Health Group Limited (EVE:ASX) does not pay a dividend.
EVE Health Group Limited (EVE:ASX) does not pay a dividend.
EVE Health Group Limited (EVE:ASX) has a franking level of 0.0%.
EVE Health Group Limited (EVE:ASX) is classified in the Healthcare.
The current P/E ratio for EVE Health Group Limited (EVE:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.